• Research
    Fibrolamellar Cancer Foundation
    Featured journal publication: October 27, 2022
    The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
    Patient resources
    Fibrolamellar Cancer
    Today's highlighted scholarship program:
    Research partners
    Fibrolamellar Cancer Foundation
    Research effort underway at Cancer Research Institute:
    previous arrowprevious arrow
    next arrownext arrow

    FCF is committed to finding a cure and supporting those impacted by fibrolamellar. 100% of donated funds are used to drive research.

    Donate Tissue

    Advance research by donating tumor tissue at no cost to you or qualifying researchers

    Find a Doctor

    Find a doctor by specialty and location


    Connect with the fibrolamellar community

    Latest News and Announcements

    FCF Partners